Cargando…

Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification

Particulate amorphous solid dispersions (ASDs) have been recognised for their potential to enhance the performance of various solid dose forms, especially oral bioavailability and macromolecule stability. However, the inherent nature of spray-dried ASDs leads to their surface cohesion/adhesion, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Suhaidi, Danni, Dong, Yao-Da, Wynne, Paul, Hapgood, Karen P., Morton, David A. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223830/
https://www.ncbi.nlm.nih.gov/pubmed/37242689
http://dx.doi.org/10.3390/pharmaceutics15051447
_version_ 1785050035226935296
author Suhaidi, Danni
Dong, Yao-Da
Wynne, Paul
Hapgood, Karen P.
Morton, David A. V.
author_facet Suhaidi, Danni
Dong, Yao-Da
Wynne, Paul
Hapgood, Karen P.
Morton, David A. V.
author_sort Suhaidi, Danni
collection PubMed
description Particulate amorphous solid dispersions (ASDs) have been recognised for their potential to enhance the performance of various solid dose forms, especially oral bioavailability and macromolecule stability. However, the inherent nature of spray-dried ASDs leads to their surface cohesion/adhesion, including hygroscopicity, which hinders their bulk flow and affects their utility and viability in terms of powder production, processing, and function. This study explores the effectiveness of L-leucine (L-leu) coprocessing in modifying the particle surface of ASD-forming materials. Various contrasting prototype coprocessed ASD excipients from both the food and pharmaceutical industries were examined for their effective coformulation with L-leu. The model/prototype materials included maltodextrin, polyvinylpyrrolidone (PVP K10 and K90), trehalose, gum arabic, and hydroxypropyl methylcellulose (HPMC E5LV and K100M). The spray-drying conditions were set such that the particle size difference was minimised, so that it did not play a substantial role in influencing powder cohesion. Scanning electron microscopy was used to evaluate the morphology of each formulation. A combination of previously reported morphological progression typical of L-leu surface modification and previously unreported physical characteristics was observed. The bulk characteristics of these powders were assessed using a powder rheometer to evaluate their flowability under confined and unconfined stresses, flow rate sensitivities, and compactability. The data showed a general improvement in maltodextrin, PVP K10, trehalose and gum arabic flowability measures as L-leu concentrations increased. In contrast, PVP K90 and HPMC formulations experienced unique challenges that provided insight into the mechanistic behaviour of L-leu. Therefore, this study recommends further investigations into the interplay between L-leu and the physico-chemical properties of coformulated excipients in future amorphous powder design. This also revealed the need to enhance bulk characterisation tools to unpack the multifactorial impact of L-leu surface modification.
format Online
Article
Text
id pubmed-10223830
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102238302023-05-28 Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification Suhaidi, Danni Dong, Yao-Da Wynne, Paul Hapgood, Karen P. Morton, David A. V. Pharmaceutics Article Particulate amorphous solid dispersions (ASDs) have been recognised for their potential to enhance the performance of various solid dose forms, especially oral bioavailability and macromolecule stability. However, the inherent nature of spray-dried ASDs leads to their surface cohesion/adhesion, including hygroscopicity, which hinders their bulk flow and affects their utility and viability in terms of powder production, processing, and function. This study explores the effectiveness of L-leucine (L-leu) coprocessing in modifying the particle surface of ASD-forming materials. Various contrasting prototype coprocessed ASD excipients from both the food and pharmaceutical industries were examined for their effective coformulation with L-leu. The model/prototype materials included maltodextrin, polyvinylpyrrolidone (PVP K10 and K90), trehalose, gum arabic, and hydroxypropyl methylcellulose (HPMC E5LV and K100M). The spray-drying conditions were set such that the particle size difference was minimised, so that it did not play a substantial role in influencing powder cohesion. Scanning electron microscopy was used to evaluate the morphology of each formulation. A combination of previously reported morphological progression typical of L-leu surface modification and previously unreported physical characteristics was observed. The bulk characteristics of these powders were assessed using a powder rheometer to evaluate their flowability under confined and unconfined stresses, flow rate sensitivities, and compactability. The data showed a general improvement in maltodextrin, PVP K10, trehalose and gum arabic flowability measures as L-leu concentrations increased. In contrast, PVP K90 and HPMC formulations experienced unique challenges that provided insight into the mechanistic behaviour of L-leu. Therefore, this study recommends further investigations into the interplay between L-leu and the physico-chemical properties of coformulated excipients in future amorphous powder design. This also revealed the need to enhance bulk characterisation tools to unpack the multifactorial impact of L-leu surface modification. MDPI 2023-05-09 /pmc/articles/PMC10223830/ /pubmed/37242689 http://dx.doi.org/10.3390/pharmaceutics15051447 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Suhaidi, Danni
Dong, Yao-Da
Wynne, Paul
Hapgood, Karen P.
Morton, David A. V.
Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title_full Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title_fullStr Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title_full_unstemmed Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title_short Bulk Flow Optimisation of Amorphous Solid Dispersion Excipient Powders through Surface Modification
title_sort bulk flow optimisation of amorphous solid dispersion excipient powders through surface modification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223830/
https://www.ncbi.nlm.nih.gov/pubmed/37242689
http://dx.doi.org/10.3390/pharmaceutics15051447
work_keys_str_mv AT suhaididanni bulkflowoptimisationofamorphoussoliddispersionexcipientpowdersthroughsurfacemodification
AT dongyaoda bulkflowoptimisationofamorphoussoliddispersionexcipientpowdersthroughsurfacemodification
AT wynnepaul bulkflowoptimisationofamorphoussoliddispersionexcipientpowdersthroughsurfacemodification
AT hapgoodkarenp bulkflowoptimisationofamorphoussoliddispersionexcipientpowdersthroughsurfacemodification
AT mortondavidav bulkflowoptimisationofamorphoussoliddispersionexcipientpowdersthroughsurfacemodification